Durable Healing Outcomes of Topical Wound Oxygen (TWO2) Therapy Highlighted at Leading International Clinical Conferences
OCEANSIDE, Calif., Aug. 26, 2021 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI) announced today that its unique multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences across the...
2,000,000 TWO2 Treatments Milestone Reached as TWO2 Study Is Highlighted in Systemic Review of Topical Oxygen Therapies
The addition of a new larger extremity-chamber to the company’s peripheral vascular disease (PVD) focused product line, allows for the application of TWO2 treatments for many more patients suffering from costly nonhealing chronic wounds.
Dr. Mike Griffiths, President and CEO of Advanced Oxygen Therapy, Inc makes the cover of Healthcare Insights.
The cover story, “Advanced Oxygen Therapy, Inc: Dedicated To Resolving Acute And Chronic Wounds Through Its Unique Multi-Modality Two2 therapy,” details the company’s mission as it fights to help patients with chronic wounds.
Advanced Oxygen Therapy Inc. Named Among the 10 Most Innovative MedTech Solution Providers to Watch in 2021
AOTI announced today that it had been named among the 10 Most Innovative MedTech Solution Providers to Watch in 2021 by the journal The Healthcare Insights and is highlighted as the cover story of its May 2021 print edition.